HR 8289 · 117th Congress · Health

Banning Misleading Drug Ads Act of 2022

Introduced 2022-07-05· Sponsored by Rep. Spanberger, Abigail Davis [D-VA-7]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2022-07-05)

Plain Language Summary

[AI summary unavailable — showing source text] Banning Misleading Drug Ads Act of 2022 This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (5)

5 Democrats